Literature DB >> 3139929

Biochemical studies on prolidase in sera from control, patients with prolidase deficiency and their mother.

T Ohhashi1, T Ohno, J Arata, H Kodama.   

Abstract

Prolidase activity in serum from normal subjects and the mother of two patients was readily detected without adding Mn2+ to the assay, and the activity was increased by addition of Mn2+ to the assay or preincubation with Mn2+. However, the activity in serum from patients with prolidase deficiency against gly-pro, leu-pro and val-pro could not be detected irrespective of Mn2+ conditions and activity against met-pro, ala-pro and phe-pro also showed a marked reduction compared to controls. Both normal and the patients' mother's prolidase activity against gly-pro was reduced about 20% at 60 degrees C compared to the activity at 37 degrees C, but the addition of Mn2+ at 55 degrees C increased the activity about 1.8-fold, whereas prolidase activity of patients could not be increased by the addition of Mn2+. The addition of Co2+ increased prolidase activity in serum from control and the patients' mother but did not increase the heat stability. These results indicate that prolidase in serum from patients with prolidase deficiency is altered rather than markedly reduced in amount.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139929     DOI: 10.1007/bf01799867

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Photometric estimation of proline and ornithine.

Authors:  F P CHINARD
Journal:  J Biol Chem       Date:  1952-11       Impact factor: 5.157

2.  Studies on a patient with iminopeptiduria. I. Identification of urinary iminopeptides.

Authors:  H Kodama; S Umemura; M Shimomura; S Mizuhara; J Arata; Y Yamamoto; A Yasutake; N Izumiya
Journal:  Physiol Chem Phys       Date:  1976

3.  Iminopeptiduria, skin ulcerations, and edema in a boy with prolidase deficiency.

Authors:  L J Sheffield; P Schlesinger; K Faull; B J Halpern; G M Schier; R G Cotton; J Hammond; D M Danks
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

4.  A prolidase deficiency in man with iminopeptiduria.

Authors:  G F Powell; M A Rasco; R M Maniscalco
Journal:  Metabolism       Date:  1974-06       Impact factor: 8.694

5.  A syndrome resembling lathyrism associated with iminodipeptiduria.

Authors:  S I Goodman; C C Solomons; F Muschenheim; C A McIntyre; B Miles; D O'Brien
Journal:  Am J Med       Date:  1968-07       Impact factor: 4.965

6.  Prolidase deficiency: characteristics of human skin fibroblast prolidase using colorimetric and fluorimetric assays.

Authors:  D A Priestman; J Butterworth
Journal:  Clin Chim Acta       Date:  1984-09-29       Impact factor: 3.786

7.  Substrate specificity of manganese-activated prolidase in control and prolidase-deficient cultured skin fibroblasts.

Authors:  J Butterworth; D Priestman
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria.

Authors:  I Myara; C Charpentier; A Lemonnier
Journal:  Clin Chim Acta       Date:  1982-10-27       Impact factor: 3.786

9.  Prolidase deficiency: its dermatological manifestations and some additional biochemical studies.

Authors:  J Arata; S Umemura; Y Yamamoto; M Hagiyama; N Nohara
Journal:  Arch Dermatol       Date:  1979-01

10.  Prolidase deficiency with iminodipeptiduria: biochemical investigations and first results of attempted therapy.

Authors:  C Charpentier; K Dagbovie; A Lemonnier; M Larregue; R A Johnstone
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

  10 in total
  4 in total

1.  Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes.

Authors:  F Endo; A Tanoue; A Kitano; J Arata; D M Danks; C M Lapière; Y Sei; S K Wadman; I Matsuda
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  Molecular defect in siblings with prolidase deficiency and absence or presence of clinical symptoms. A 0.8-kb deletion with breakpoints at the short, direct repeat in the PEPD gene and synthesis of abnormal messenger RNA and inactive polypeptide.

Authors:  A Tanoue; F Endo; I Akaboshi; T Oono; J Arata; I Matsuda
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  Prolidase deficiency: biochemical classification of alleles.

Authors:  A P Boright; C R Scriver; G A Lancaster; F Choy
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

4.  Quantitative analysis of the natural history of prolidase deficiency: description of 17 families and systematic review of published cases.

Authors:  Francis Rossignol; Marvid S Duarte Moreno; Carlos R Ferreira; Manuel Schiff; Jean-François Benoist; Manfred Boehm; Emmanuelle Bourrat; Aline Cano; Brigitte Chabrol; Claudine Cosson; José Luís Dapena Díaz; Arthur D'Harlingue; David Dimmock; Alexandra F Freeman; María Tallón García; Cheryl Garganta; Tobias Goerge; Sara S Halbach; Jan de Laffolie; Christina T Lam; Ludovic Martin; Esmeralda Martins; Andrea Meinhardt; Isabelle Melki; Amanda K Ombrello; Noémie Pérez; Dulce Quelhas; Anna Scott; Anne M Slavotinek; Ana Rita Soares; Sarah L Stein; Kira Süßmuth; Jenny Thies
Journal:  Genet Med       Date:  2021-05-26       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.